Annual Working Capital
$275.71 M
-$123.70 M-30.97%
31 December 2023
Summary:
Centessa Pharmaceuticals annual working capital is currently $275.71 million, with the most recent change of -$123.70 million (-30.97%) on 31 December 2023. During the last 3 years, it has risen by +$273.16 million (+10729.03%). CNTA annual working capital is now -54.36% below its all-time high of $604.14 million, reached on 31 December 2021.CNTA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$541.96 M
+$213.21 M+64.86%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly working capital is currently $541.96 million, with the most recent change of +$213.21 million (+64.86%) on 30 September 2024. Over the past year, it has increased by +$244.46 million (+82.17%). CNTA quarterly working capital is now -12.52% below its all-time high of $619.50 million, reached on 30 June 2021.CNTA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.0% | +82.2% |
| 3 y3 years | +10000.0% | -7.0% |
| 5 y5 years | +10000.0% | - |
CNTA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -54.4% | >+9999.0% | -10.3% | +110.8% |
| 5 y | 5 years | -54.4% | +9796.7% | -12.5% | +110.8% |
| alltime | all time | -54.4% | +417.0% | -12.5% | +110.8% |
Centessa Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $541.96 M(+64.9%) |
| June 2024 | - | $328.75 M(+27.9%) |
| Mar 2024 | - | $257.04 M(-6.8%) |
| Dec 2023 | $275.71 M(-31.0%) | $275.71 M(-7.3%) |
| Sept 2023 | - | $297.50 M(-6.0%) |
| June 2023 | - | $316.55 M(-10.7%) |
| Mar 2023 | - | $354.64 M(-11.2%) |
| Dec 2022 | $399.41 M(-33.9%) | $399.41 M(-9.0%) |
| Sept 2022 | - | $438.80 M(-9.7%) |
| June 2022 | - | $485.93 M(-12.3%) |
| Mar 2022 | - | $554.00 M(-8.3%) |
| Dec 2021 | $604.14 M | $604.14 M(+3.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $582.50 M(-6.0%) |
| June 2021 | - | $619.50 M(+110.2%) |
| Mar 2021 | - | $294.66 M |
| Dec 2020 | $2.55 M(-189.5%) | - |
| June 2020 | -$2.84 M(-447.6%) | - |
| June 2019 | $818.00 K(-100.9%) | - |
| June 2018 | -$86.97 M(+138.1%) | - |
| June 2017 | -$36.53 M(-611.7%) | - |
| June 2016 | $7.14 M(+22.3%) | - |
| June 2015 | $5.84 M(<-9900.0%) | - |
| May 2015 | -$44.10 K(-712.5%) | - |
| May 2014 | $7200.00 | - |
FAQ
- What is Centessa Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual working capital year-on-year change?
- What is Centessa Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly working capital year-on-year change?
What is Centessa Pharmaceuticals annual working capital?
The current annual working capital of CNTA is $275.71 M
What is the all time high annual working capital for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual working capital is $604.14 M
What is Centessa Pharmaceuticals annual working capital year-on-year change?
Over the past year, CNTA annual working capital has changed by -$123.70 M (-30.97%)
What is Centessa Pharmaceuticals quarterly working capital?
The current quarterly working capital of CNTA is $541.96 M
What is the all time high quarterly working capital for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly working capital is $619.50 M
What is Centessa Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, CNTA quarterly working capital has changed by +$244.46 M (+82.17%)